Ryvu Therapeutics Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	49.7	59.61	160.07	57.94	101.92	83.24
Short-Term Investments	33.41	48.07	65.86	193.21	243.49	4.99
Cash & Short-Term Investments	83.11	107.68	225.93	251.15	345.41	88.23
Cash Growth	-54.36%	-52.34%	-10.04%	-27.29%	291.49%	-45.26%
Accounts Receivable	22.45	20.1	35.78	32.84	16.93	11.74
Inventory	1.34	1.34	1.21	-	1.76	1.96
Other Current Assets	9.99	10.14	9.52	-	3.83	2.32
Total Current Assets	116.88	139.25	272.44	283.99	367.93	104.25
Net Property, Plant & Equipment	68.27	70.02	72.74	-	80.35	91.18
Other Intangible Assets	6.31	6.04	8.12	-	1.87	3.04
Long-Term Investments	6.62	6.38	16.79	-	20.55	30.01
Other Long-Term Assets	2.88	2.75	8.7	-	4.28	0.33
Total Assets	200.96	224.44	378.78	403.2	474.98	228.81
Accounts Payable	14.62	19.72	35.75	-	15.5	20.92
Accrued Expenses	2.34	2.11	9.89	-	10.7	3.59
Short-Term Debt	0.04	0.11	0.29	-	0.87	0.83
Current Portion of Leases	0.35	0.38	0.5	-	1.03	1.92
Unearned Revenue	20.42	23.19	35.71	-	16.71	8.95
Other Current Liabilities	13.97	16.08	25.79	-	-	-
Total Current Liabilities	51.73	61.58	107.93	69.7	44.81	36.2
Long-Term Debt	72.39	70.27	64.92	-	-	0.74
Long-Term Leases	0.87	0.96	1.39	-	0.87	1.58
Other Long-Term Liabilities	34.65	37.79	52.24	-	85.91	28.99
Total Long-Term Liabilities	107.9	109.02	118.56	73.91	86.77	31.31
Total Liabilities	159.63	170.6	226.48	143.61	131.59	67.51
Common Stock	9.25	9.25	9.25	9.25	7.34	7.34
Additional Paid-in Capital	257.4	257.26	254.49	-	243.95	-21.92
Retained Earnings	-225.32	-212.67	-111.44	-	92.1	175.88
Total Common Shareholders' Equity	41.33	53.83	152.29	9.25	343.39	161.3
Shareholders' Equity	41.33	53.83	152.29	259.59	343.39	161.3
Total Liabilities & Equity	200.96	224.44	378.78	403.2	474.98	228.81
Total Debt	73.64	71.72	67.11	0	2.77	5.07
Net Cash (Debt)	9.46	35.96	158.83	251.15	342.64	83.16
Net Cash Growth	-91.23%	-77.36%	-36.76%	-26.70%	312.02%	-45.92%
Net Cash Per Share	0.41	1.55	6.87	10.97	18.67	4.53
Book Value	41.33	53.83	152.29	9.25	343.39	161.3
Book Value Per Share	1.79	2.33	6.59	0.40	18.71	8.79
Tangible Book Value	35.02	47.79	144.18	9.25	341.52	158.26
Tangible Book Value Per Share	1.51	2.07	6.24	0.40	18.61	8.62